@article{ce4ab2028227472996de10b9e6470885,
title = "The quest for dementia prevention does not include an aspirin a day",
author = "Knopman, {David S.} and Petersen, {Ronald C.}",
note = "Funding Information: Funded by NIH grants P50 AG016574 and P30 AG062677. Funding Information: D. S. Knopman served on a Data Safety Monitoring Board for the Dominantly Inherited Alzheimer Network (DIAN) study. He serves on a Data Safety Monitoring Board for a tau therapeutic for Biogen but receives no personal compensation. He is an investigator in clinical trials sponsored by Biogen, Lilly Pharmaceuticals, and the University of Southern California. He serves as a consultant for Samus Therapeutics, Third Rock, and Alzeca Biosciences but receives no personal compensation. He receives research support from the NIH. R. C. Petersen is a consultant for Biogen, Inc, Roche, Inc, Merck, Inc, Genentech Inc, and Eisai, Inc; has given educational lectures for GE Healthcare; receives publishing royalties from Mild Cognitive Impairment (Oxford University Press, 2003) and UpToDate; and receives research support from the NIH/ National Institute on Aging. Go to Neurology.org/N for full disclosures.",
year = "2020",
month = jul,
day = "21",
doi = "10.1212/WNL.0000000000009278",
language = "English (US)",
volume = "95",
pages = "105--106",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "3",
}